Fasting and time-restricted eating

Fasting earns its reputation from the aging biology it engages — it lowers the cell's growth signalling, switches on cellular self-cleaning, and triggers a wave of tissue renewal when you eat again — but the human longevity evidence is still a single moved biological-age clock, not a lifespan trial, and the weight loss it is actually marketed for is no better than ordinary calorie restriction. The most useful version is also the easiest: a consistent 12–14 hour overnight fast, anchored to the morning rather than the evening.

The reason fasting belongs in a longevity discussion at all is mechanistic. Going without food for long enough flips a metabolic switch — insulin and the growth pathways fall, the cell's low-fuel sensors come on, and the recycling machinery that clears damaged proteins and organelles is released. In animals this reliably extends lifespan. In humans the strongest signal so far is a small trial in which a fasting-style diet moved a validated biological-age clock; no randomised trial has ever tested whether fasting makes people live longer. Intermittent fasting has also been the most popular dietary "movement" of the last decade, and the weight-loss trials are now substantial enough to settle that question separately: it works, but no better than eating less the ordinary way. This article walks the longevity case first, then the metabolism, the weight-loss reality, the window-length question — how many hours actually matter — and the safety considerations.

Four protocols, distinguished

Protocol	Description	Best evidence
Time-restricted eating (TRE)	Daily eating compressed into a 6–10 hour window (most commonly 16 hours fasting / 8 hours eating, written "16:8")	Best-studied; early-day windows clearly superior to late-day
Alternate-day fasting (ADF)	Days of normal eating alternating with days of ~25% of energy needs	~5–8% weight loss over 8–12 weeks; adherence drops sharply long-term
Periodic fasting	Single multi-day fasts (24–72 hours, occasionally longer)	Stronger autophagy signals; harder to maintain
Fasting-mimicking diet (FMD)	Five-day low-calorie, low-protein, plant-based protocol designed to trigger fasting biology while still allowing some food	Multiple human trials (Wei et al., Sci Transl Med 2017); typically 4 cycles per year

The vast majority of public attention has focused on 16:8 time-restricted eating. The evidence base on TRE has matured the most; the others are less well-studied in humans.

What the evidence actually says

The longevity case — strong in animals, unproven in humans

This is the honest centre of the topic. No randomised trial has tested whether intermittent fasting extends human lifespan. The animal evidence — in rodents, nematodes, and yeast — is strong and consistent for both caloric restriction and various fasting protocols, and it is mechanistically coherent: fasting hits the same nutrient-sensing pathways that, when dialled down, lengthen life across species (see Deregulated nutrient sensing). The translation to human lifespan is plausible but unproven, and marketers routinely blur that line. Don't.

The best human evidence is a surrogate, not a lifespan outcome. A clinical trial of the fasting-mimicking diet found that three monthly cycles cut participants' biological age by a median of about 2.5 years on a validated clock — independent of weight loss — alongside lower insulin resistance, less liver fat measured by imaging, and a shift in the immune-cell profile (a higher lymphoid-to-myeloid ratio) toward a younger state.^[1] That is the same intervention, and the same roughly 2.5-year figure, discussed under deregulated nutrient sensing. It is genuinely encouraging — but it is one small trial, measuring a biological-age estimate rather than survival.

The metabolic switch and autophagy

The cellular mechanism is the part that is real and well-characterised. A long enough fast raises the cell's ratio of "spent" to "charged" energy currency, which activates the low-fuel sensor AMP-activated protein kinase (AMPK); at the same time, falling insulin, falling insulin-like growth factor 1 (IGF-1), and dropping amino-acid levels switch off the master growth regulator mTOR. With the growth signal down and the fuel sensor up, the cell shifts from building and storing to repairing and recycling.

That recycling is autophagy — the system that clears damaged organelles and misfolded proteins, and a hallmark of aging in its own right (see Disabled macroautophagy). A single five-day fasting-mimicking diet cycle moves measurable autophagy markers in human blood cells, and the effect persists into refeeding. Ramadan fasting (dawn-to-sunset for a month, an extended form of time-restricted eating) shifts the same markers toward active autophagy. Two caveats keep this honest:

Exercise activates autophagy through the same AMPK pathway, with measurable effects after sessions lasting roughly an hour. You don't need a fast to engage the system.
Age-related decline in autophagic capacity is real. Older adults respond less robustly to the same fasting stimulus than younger adults — the cellular machinery itself is part of what aging degrades.

Refeeding is half the story

The fast gets the attention, but recent work points to the refeeding transition as where much of the longevity benefit — and a real risk — is actually generated.

On the benefit side, a 2026 study in the roundworm C. elegans found that fasting's lifespan extension depends on how cleanly the animal switches back to a fed state. During the fast, a lipid-metabolism regulator (the receptor NHR-49) keeps fat-burning genes switched on; on refeeding, an enzyme (KIN-19) chemically silences it, and the metabolic gears re-engage. Engineer the worms so that regulator can't be switched off at refeeding, and the lifespan gain disappears entirely — even though the fast itself was unchanged.^[2] The finding is in worms, not people, so it is a mechanistic clue rather than human guidance — but it reframes fasting as a fast-and-refeed cycle, not a fast alone.

On the risk side, the same refeeding window carries a downside. Animal models show that the burst of cell proliferation after a long fast — exactly the tissue renewal that makes refeeding regenerative — comes with a transient elevated proliferation signal that can, in some contexts, accelerate tumour growth if a cancer-driving mutation is already present.^[3] Human relevance is unclear, but it argues against habitual very-long fasts for anyone with a cancer history.

Blood-sugar control — the strongest measured human benefit

Where fasting clearly delivers in humans is glucose handling. Intermittent fasting produces modest improvements in fasting glucose, fasting insulin, and HbA1c (the three-month blood-sugar average) in healthy adults, and the signal is biggest in type 2 diabetes and prediabetes. Used as an adjunct to standard care, fasting protocols cut HbA1c by roughly 0.5% in adults on oral diabetes drugs and by up to 2.8% in insulin-dependent diabetes — though the latter requires close medical supervision because of low-blood-sugar risk.^[4] The effect is real but should not be oversold: in a year-long randomised trial of adults with metabolic syndrome (the TIMET trial), a personalised time-restricted-eating schedule added to standard care improved HbA1c by just −0.10% versus standard care alone, with no major adverse events.^[5]

The mechanism is straightforward: long fasting windows let insulin fall and fat-burning run, which uses up the toxic fat stored inside muscle cells that drives insulin resistance. See Metabolic flexibility for the cellular detail.

Early eating beats late eating at matched calories

The clearest piece of timing evidence: eating earlier in the day produces better metabolic outcomes than eating later, even when total calories are identical. A 2024 network meta-analysis of time-restricted-eating trials found early-day windows produced a measurably better fasting-insulin response than late-day windows.^[6] The landmark mechanistic study — five weeks of early time-restricted feeding (eating between roughly 8:00 and 14:00) in men with prediabetes — improved insulin sensitivity, blood pressure, oxidative stress, and evening appetite without any weight loss.^[7]

The biology underneath this is the same circadian story that shows up everywhere on this site (see Circadian rhythms):

Pancreatic insulin secretion is faster and more efficient in the biological morning.
The same meal eaten at 20:00 produces a glucose excursion roughly 50% larger than at 08:00 in crossover trials.
The liver clock anticipates the feeding window — eating outside it produces metabolic friction with the liver's glucose handling.
Late eating raises late-night metabolic rate, blunts the core-temperature drop that initiates sleep, and degrades sleep architecture.

Practical implication: a "skip breakfast, big late dinner" version of 16:8 is probably the worst chronotype for fasting. A "breakfast and lunch as the main meals, light early dinner finishing by 17:00–19:00" pattern aligns the eating window with the circadian biology.

Weight loss — the marketed benefit, no better than calorie restriction

This is the claim fasting is sold on, and the one the human trials have most decisively cut down to size. The 2025 BMJ network meta-analysis pooled 99 randomised trials covering 6,582 participants. All intermittent fasting strategies produced weight loss versus eating ad libitum. The comparison versus continuous calorie restriction was much closer: alternate-day fasting had a small statistical edge (roughly 1.3 kg better) in short trials, and that difference disappeared entirely in trials longer than 24 weeks.^[8] A 2026 Cochrane review of 22 trials reached the same conclusion: no significant additional weight loss versus standard dietary advice.^[9]

The honest reading: intermittent fasting is one acceptable structure for eating less, not a metabolically privileged route to weight loss. People who find a structured window easier to maintain than counting calories often benefit; people who find skipping breakfast destabilising do not.

Cardiometabolic markers — modest, and they fade without adherence

Blood pressure, lipid profile, and inflammatory markers (C-reactive protein, interleukin-6) all move favourably across most fasting protocols, but the effect sizes are smaller and more variable than for glucose, and most of the variance washes out when fasting is compared against an equivalent calorie-restriction control. They are also not durable: the cardiovascular improvements typically appear within a few weeks of starting a structured regimen and dissipate within weeks of returning to unrestricted eating — the benefit rides on sustained adherence, not on a one-time reset.

The 8-hour caution and other concerning signals

A 2024 American Heart Association meeting abstract reported a 91% higher cardiovascular mortality in adults with self-reported eating windows under 8 hours, in an analysis of a large US nutrition survey.^[10] That abstract has since been published in full, and the picture it leaves is reassuring rather than alarming.^[11] The cardiovascular signal persisted — and nominally rose to a hazard ratio of 2.35 against a narrower 12–14 hour reference window — but the all-cause and cancer-mortality associations were not significant, the all-cause link did not survive sensitivity analyses, and the authors themselves retreated to whether the risk reflects "the short eating duration itself or residual confounding." The estimate rests on roughly 414 people (≈2% of the sample, ~31 cardiovascular deaths) who were younger, more often smokers, and food-insecure — never verified to be deliberate fasters — and the expert consensus (including a letter from 34 fasting researchers to the AHA) is that the signal is most plausibly confounded, not causal. A separate cohort finds the same U-shape: lowest mortality at an ~11–12 hour window, with both very short (<8 h) and very long (≥15 h) windows linked to higher risk, again with reverse causation flagged.^[12] Worth knowing; not a reason to abandon early TRE.
Severe time-restricted eating under 6 hours sustained long-term has not been adequately studied for safety — particularly cardiovascular safety in adults with established disease.
The refeeding proliferation signal (above) argues against habitual very-long fasts in adults with a cancer history.
Rapid weight loss raises gallstone risk. Losing weight faster than about 1.5 kg per week — which aggressive fasting can drive — prompts the liver to dump extra cholesterol into bile while the gallbladder empties less often, a well-established trigger for gallstones. It is an argument for a moderate pace, not a reason to avoid fasting.

The window-length question: how many hours?

This is the question most people actually arrive with — fast for 8, 10, 12 hours, or more? The trial data sorts daily eating windows into three useful tiers.

Short (eating window under 8 hours — i.e. fasting 16+ hours daily). Produces the fastest metabolic and weight effects, but adherence is poor — hunger, fatigue, irritability, and social friction drive high dropout — and this is the band where the cardiovascular-mortality signal sits. Not a sensible default.
Moderate (8–12 hour eating window — i.e. fasting 12–16 hours). The sweet spot. Consistent improvements in blood sugar, lipids, blood pressure, and visceral fat, with the best long-term adherence and the easiest fit to a normal day and to circadian biology.^[13]
Long (eating window over 12 hours — i.e. fasting under 12 hours). Effortless to sustain, but probably too short a fast to trigger a robust metabolic switch or much autophagy.

The key point is that there is no simple "longer is better" dose-response. Beyond about 16 hours of daily fasting the added benefit is small and the adherence and safety costs rise, and when you eat (early) matters at least as much as how long you fast. For most people the moderate band — a 12–14 hour overnight fast, nudged toward 16:8 if they want more and tolerate it well — captures essentially all of the realistic benefit.

The training interaction

A reasonable question: can you build muscle and intermittently fast? The answer is yes, with caveats.

Resistance training requires adequate total protein and energy. Fasted training is fine; the post-training meal, with protein, is what supports adaptation.
A 16:8 eating window is compatible with hypertrophy. Most adults can hit ~140–160 g of protein in an 8-hour window if they plan it — three meals at ~40–50 g protein each, with the post-training meal at the top end.
The pre-sleep protein finding — a ~40 g pre-sleep casein meal improves overnight muscle protein synthesis — directly conflicts with strict early-TRE protocols. See Protein for the detail.

The reason this matters: fasting-induced weight loss is not all fat. In a four-week alternate-day-fasting trial, roughly a third of the weight lost was lean tissue — and a low dose of protein (25 g) on fasting days did not prevent it.^[14] Across the wider TRE literature the same caution holds: fat loss is reliable, but lean mass can fall unless protein and resistance training are deliberately added.^[15] The fix is the one this section already describes — adequate total protein (aim for at least 1.2–1.6 g/kg/day) plus resistance training preserves muscle while the fat comes off; the timing of the window matters far less than hitting that protein target.

The reasonable compromise: most days, an early or moderate TRE window (eating between, say, 8:00 and 18:00). On heavy training days, allow flexibility — including a post-training meal even if it pushes the window slightly later than usual.

Who should not fast

The contraindication list is short and important.

Pregnancy and lactation.
Type 1 diabetes, except under explicit medical supervision.
History of disordered eating — fasting can trigger or reinforce restrictive patterns, and the data on safety is not on the side of the people most drawn to the protocol. In a survey of nearly 2,800 Canadian adolescents and young adults, intermittent fasting was common (used in the past year by about 48% of women and 38% of men) and, in women, was associated with the full range of eating-disorder behaviours — binge eating, loss of control, vomiting, laxative use, and compulsive exercise.^[16] This is the most clinically important safety signal, and it is concentrated in young women.
Underweight adults.
Children and adolescents.
Insulin or sulfonylurea users — extreme low-blood-sugar risk; only under explicit medical supervision.
Frail older adults — protein intake and muscle preservation are more important than fasting at this stage, and the risk of muscle loss dominates. See Protein.

Women's metabolic response to extended fasting is also somewhat different from men's; the literature is thinner but consistent enough to recommend that pre-menopausal women experiment cautiously with windows shorter than 14 hours and stay attentive to menstrual-cycle disruption as a stop signal.

Practical protocols

For most healthy midlife adults, the simplest evidence-based starting point is the easiest one — and the gains from going more aggressive are small.

Daily 12–14 hour overnight fast (the recommended default)

Last bite of food around 19:00; first food at 7:00–9:00 the next morning.
Aligns with circadian biology.
Effortlessly compatible with normal social patterns.
Low downside risk.

Daily 16:8 with an early window (for those who want more)

Eat between 9:00 and 17:00, or 10:00 and 18:00.
Strongest mechanistic signal in the trial data for adults without metabolic disease.
Compatible with morning training; awkward with late-evening social meals.

Periodic deeper fasts (optional)

A 24-hour fast (dinner to dinner) once a week is a moderate intervention with low cost.
One fasting-mimicking diet cycle (five days) per year is a reasonable option for adults drawn to the longevity and autophagy framework; the evidence base is real but small. If you do a multi-day fast, the refeeding matters as much as the fast — reintroduce food gradually rather than breaking a long fast with a large meal.

What to skip. Aggressive alternate-day fasting, multi-day water-only fasts without medical supervision, and one-meal-a-day patterns sustained long-term — the adherence cost is high, the metabolic upside over moderate TRE is small, and the muscle and bone consequences accumulate.

What's overrated

"Fasting reverses aging." The cellular mechanisms are real and the animal lifespan data is strong, but no human trial has shown fasting extends life — and the equivalent claim in humans is doing most of the marketing work behind the protocols people pay for.
OMAD (one meal a day) sustained long-term. Adherence and muscle-mass cost versus the metabolic upside over moderate TRE; not justified by the data.
Multi-day water-only fasts as "cellular cleanse." Autophagy is real; the supplement industry has wrapped legitimate biology in spa-day language that doesn't match the evidence.
Late-day TRE. Skipping breakfast to eat a heavy late dinner is the worst chronotype combination for the same total fasting window.